Serum levels of the extracellular domain of the epidermal growth factor receptor in individuals exposed to arsenic in dringking water in Bangladesh

Y. Li, Yu Chen, V. Slavkovic, H. Ahsan, F. Parvez, J. H. Graziano, P. W. Brandt-Rauf

Research output: Contribution to journalArticle

Abstract

Epidermal growth factor receptor-dependent mechanisms have been implicated in growth signal transduction pathways that contribute to cancer development, including dermal carcinogenesis. Detection of the extracellular domain of the epidermal growth factor receptor (EGFR ECD) in serum has been suggested as a potential biomarker for monitoring this effect in vivo. Arsenic is a known human carcinogen, producing skin and other malignancies in populations exposed through their drinking water. One such exposed population, which we have been studying for a number of years, is in Bangladesh. The purpose of this study was to examine the EGFR ECD as a potential biomarker of arsenic exposure and/or effect in this population. Levels of the EGFR ECD were determined by enzyme-linked immunosorbent assay in the serum samples from 574 individuals with a range of arsenic exposures from drinking water in the Araihazar area of Bangladesh. In multiple regression analysis, serum EGFR ECD was found to be positively associated with three different measures of arsenic exposure (well water arsenic, urinary arsenic and a cumulative arsenic index) at statistically significant levels (p≤0.034), and this association was strongest among the individuals with arsenic-induced skin lesions (p≤0.002). When the study subjects were stratified in tertiles of serum EGFR ECD levels, the risk of skin lesions increased progressively for each increase in all three arsenic measures (also stratified in tertiles) and this increasing risk became more pronounced among subjects within the highest tertile of EGFR ECD levels. These results suggest that serum EGFR ECD levels may be a potential biomarker of effect of arsenic exposure and may indicate those exposed individuals at greatest risk for the development of arsenic-induced skin lesions.

Original languageEnglish (US)
Pages (from-to)256-265
Number of pages10
JournalBiomarkers
Volume12
Issue number3
DOIs
StatePublished - May 2007

Fingerprint

Bangladesh
Arsenic
Epidermal Growth Factor Receptor
Water
Serum
Skin
Biomarkers
Drinking Water
Population
Signal transduction
Immunosorbents
Regression analysis
Carcinogens
Assays
Signal Transduction
Neoplasms
Carcinogenesis
Enzyme-Linked Immunosorbent Assay
Regression Analysis
Association reactions

Keywords

  • Arsenic
  • Biomarker of effect
  • Epidermal growth factor receptor (EGFR)
  • Skin lesions

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Health, Toxicology and Mutagenesis

Cite this

Serum levels of the extracellular domain of the epidermal growth factor receptor in individuals exposed to arsenic in dringking water in Bangladesh. / Li, Y.; Chen, Yu; Slavkovic, V.; Ahsan, H.; Parvez, F.; Graziano, J. H.; Brandt-Rauf, P. W.

In: Biomarkers, Vol. 12, No. 3, 05.2007, p. 256-265.

Research output: Contribution to journalArticle

Li, Y. ; Chen, Yu ; Slavkovic, V. ; Ahsan, H. ; Parvez, F. ; Graziano, J. H. ; Brandt-Rauf, P. W. / Serum levels of the extracellular domain of the epidermal growth factor receptor in individuals exposed to arsenic in dringking water in Bangladesh. In: Biomarkers. 2007 ; Vol. 12, No. 3. pp. 256-265.
@article{6788e455211846ba946c4456c2ecd468,
title = "Serum levels of the extracellular domain of the epidermal growth factor receptor in individuals exposed to arsenic in dringking water in Bangladesh",
abstract = "Epidermal growth factor receptor-dependent mechanisms have been implicated in growth signal transduction pathways that contribute to cancer development, including dermal carcinogenesis. Detection of the extracellular domain of the epidermal growth factor receptor (EGFR ECD) in serum has been suggested as a potential biomarker for monitoring this effect in vivo. Arsenic is a known human carcinogen, producing skin and other malignancies in populations exposed through their drinking water. One such exposed population, which we have been studying for a number of years, is in Bangladesh. The purpose of this study was to examine the EGFR ECD as a potential biomarker of arsenic exposure and/or effect in this population. Levels of the EGFR ECD were determined by enzyme-linked immunosorbent assay in the serum samples from 574 individuals with a range of arsenic exposures from drinking water in the Araihazar area of Bangladesh. In multiple regression analysis, serum EGFR ECD was found to be positively associated with three different measures of arsenic exposure (well water arsenic, urinary arsenic and a cumulative arsenic index) at statistically significant levels (p≤0.034), and this association was strongest among the individuals with arsenic-induced skin lesions (p≤0.002). When the study subjects were stratified in tertiles of serum EGFR ECD levels, the risk of skin lesions increased progressively for each increase in all three arsenic measures (also stratified in tertiles) and this increasing risk became more pronounced among subjects within the highest tertile of EGFR ECD levels. These results suggest that serum EGFR ECD levels may be a potential biomarker of effect of arsenic exposure and may indicate those exposed individuals at greatest risk for the development of arsenic-induced skin lesions.",
keywords = "Arsenic, Biomarker of effect, Epidermal growth factor receptor (EGFR), Skin lesions",
author = "Y. Li and Yu Chen and V. Slavkovic and H. Ahsan and F. Parvez and Graziano, {J. H.} and Brandt-Rauf, {P. W.}",
year = "2007",
month = "5",
doi = "10.1080/13547500601133939",
language = "English (US)",
volume = "12",
pages = "256--265",
journal = "Biomarkers",
issn = "1354-750X",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Serum levels of the extracellular domain of the epidermal growth factor receptor in individuals exposed to arsenic in dringking water in Bangladesh

AU - Li, Y.

AU - Chen, Yu

AU - Slavkovic, V.

AU - Ahsan, H.

AU - Parvez, F.

AU - Graziano, J. H.

AU - Brandt-Rauf, P. W.

PY - 2007/5

Y1 - 2007/5

N2 - Epidermal growth factor receptor-dependent mechanisms have been implicated in growth signal transduction pathways that contribute to cancer development, including dermal carcinogenesis. Detection of the extracellular domain of the epidermal growth factor receptor (EGFR ECD) in serum has been suggested as a potential biomarker for monitoring this effect in vivo. Arsenic is a known human carcinogen, producing skin and other malignancies in populations exposed through their drinking water. One such exposed population, which we have been studying for a number of years, is in Bangladesh. The purpose of this study was to examine the EGFR ECD as a potential biomarker of arsenic exposure and/or effect in this population. Levels of the EGFR ECD were determined by enzyme-linked immunosorbent assay in the serum samples from 574 individuals with a range of arsenic exposures from drinking water in the Araihazar area of Bangladesh. In multiple regression analysis, serum EGFR ECD was found to be positively associated with three different measures of arsenic exposure (well water arsenic, urinary arsenic and a cumulative arsenic index) at statistically significant levels (p≤0.034), and this association was strongest among the individuals with arsenic-induced skin lesions (p≤0.002). When the study subjects were stratified in tertiles of serum EGFR ECD levels, the risk of skin lesions increased progressively for each increase in all three arsenic measures (also stratified in tertiles) and this increasing risk became more pronounced among subjects within the highest tertile of EGFR ECD levels. These results suggest that serum EGFR ECD levels may be a potential biomarker of effect of arsenic exposure and may indicate those exposed individuals at greatest risk for the development of arsenic-induced skin lesions.

AB - Epidermal growth factor receptor-dependent mechanisms have been implicated in growth signal transduction pathways that contribute to cancer development, including dermal carcinogenesis. Detection of the extracellular domain of the epidermal growth factor receptor (EGFR ECD) in serum has been suggested as a potential biomarker for monitoring this effect in vivo. Arsenic is a known human carcinogen, producing skin and other malignancies in populations exposed through their drinking water. One such exposed population, which we have been studying for a number of years, is in Bangladesh. The purpose of this study was to examine the EGFR ECD as a potential biomarker of arsenic exposure and/or effect in this population. Levels of the EGFR ECD were determined by enzyme-linked immunosorbent assay in the serum samples from 574 individuals with a range of arsenic exposures from drinking water in the Araihazar area of Bangladesh. In multiple regression analysis, serum EGFR ECD was found to be positively associated with three different measures of arsenic exposure (well water arsenic, urinary arsenic and a cumulative arsenic index) at statistically significant levels (p≤0.034), and this association was strongest among the individuals with arsenic-induced skin lesions (p≤0.002). When the study subjects were stratified in tertiles of serum EGFR ECD levels, the risk of skin lesions increased progressively for each increase in all three arsenic measures (also stratified in tertiles) and this increasing risk became more pronounced among subjects within the highest tertile of EGFR ECD levels. These results suggest that serum EGFR ECD levels may be a potential biomarker of effect of arsenic exposure and may indicate those exposed individuals at greatest risk for the development of arsenic-induced skin lesions.

KW - Arsenic

KW - Biomarker of effect

KW - Epidermal growth factor receptor (EGFR)

KW - Skin lesions

UR - http://www.scopus.com/inward/record.url?scp=34247563329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247563329&partnerID=8YFLogxK

U2 - 10.1080/13547500601133939

DO - 10.1080/13547500601133939

M3 - Article

VL - 12

SP - 256

EP - 265

JO - Biomarkers

JF - Biomarkers

SN - 1354-750X

IS - 3

ER -